Supreme Court Rejects Limits on Drug-Injury Lawsuits

Case involved Vermont musician who lost her arm to anti-nausea drug In a long-awaited legal decision, the U.S. Supreme Court ruled Wednesday that patients who are injured by a drug can sue the drug’s manufacturer for damages, even if the drug has been granted FDA approval. The decision, in the lawsuit Wyeth v. Levine, upheld […]

Ascenta Therapeutics Announces Positive Preliminary Results With AT-101 In Docetaxel Refractory Prostate Cancer

Ascenta Therapeutics announced positive preliminary results from its Phase II study of AT-101 in combination with docetaxel and prednisone (D/P) in men with docetaxel refractory, castrate resistant prostate cancer (CRPC) at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium in Orlando, FL. AT-101, an oral, pan-Bcl-2 inhibitor currently in double-blinded, randomized Phase II […]

Heart Drugs: Brand Names No Better Than Generics, Study

US scientists reviewing 20 years of research and expert opinion on generic versus brand name drugs in the treatment of cardiovascular diseases found no clinical evidence showing brand names were superior to generic versions even though a substantial number of experts writing editorials advised against interchanging them. The study was the work of Dr Aaron […]

Practical Management Of Norovirus Outbreaks – A New One-Day Course From The Royal Institute Of Public Health, Tuesday 13th May 2008, UK

Noroviruses are a group of viruses that are the most common cause of acute gastroenteritis and the HPA estimates that they affect between 600,000 and a million people in the UK each year. Infection can spread rapidly, and as Norovirus outbreaks continue to hit the headlines, the RIPH is pleased to announce it is running […]

Cheaper Drugs Now Closer To Realization With New DropArray Technology

A standard laboratory tool for measuring pharmacological activity of biological substances and performing other related tests may soon be replaced by a new miniaturized bioassay that will be faster, cheaper and more efficient for scientists to use, with new technology developed by Singapore’s Institute of Bioengineering and Nanotechnology (IBN). The new assay, named DropArray, slashes […]

“Generics: The Right Choice For Better Health” Is Theme Of GPhA’s 2007 Annual Meeting

The Generic Pharmaceutical Association (GPhA) will host its 2008 Annual Meeting, “Generics: the Right Choice for Better Health,” on February 11-13, 2008, in Boca Raton, Florida. Featuring presentations from government, industry and Wall Street leaders, the meeting will examine the current healthcare environment and generics’ critical role in promoting affordable healthcare in the United States. […]

Blockbuster Renewable Fuel Standard Plus Advances In Biotechnology Will Transform U.S. Energy Picture And Economy, BIO Says

The Biotechnology Industry Organization (BIO) applauded President Bush and Congress for enacting the Energy Independence and Security Act of 2007, containing the new renewable fuel standard (RFS) that explicitly supports production of 36 billion gallons of biofuels, including cellulosic ethanol and advanced biofuels. Brent Erickson, executive vice president for BIO’s Industrial and Environmental Section, issued […]

Nearly 700 New Medications In Development To Treat Diseases Affecting Blacks, PhRMA Report Says

Drug companies are working on 691 new medicines that treat diseases disproportionately affecting blacks, according to a report issued by the Pharmaceutical Research and Manufacturers of America, the Memphis Business Journal reports. According to the report, * 229 of the drugs are for cancers that disproportionately affect blacks; * 114 address cardiovascular disease; * 95 […]

The Informed Patient: What The European Union Has To Do

The three representatives of the European Parliament in the EU High Level Pharmaceutical Forum, Francoise Grossetete, Dagmar Roth-Behrendt and Jorgo Chatzimarkakis, hosted a conference entitled The informed patient – What the European Union has to do at the European Parliament in Brussels. A wide range of European stakeholders discussed concrete ways to reduce the current […]

Wall Street Journal Examines Challenges Drug Industry Will Face In Coming Years

“Over the next few years, the pharmaceutical industry will hit a wall,” the Wall Street Journal reports in an examination of challenges that face large pharmaceutical companies. In future years, some of the “top-selling drugs in industry history will become history as patent protections expire,” with generic competition “expected to wipe $67 billion from top […]